SCHEMBL632817

SCHEMBL632817

CC1CCCC(C(=O)O)(C(=O)OC(=O)C2(C(=O)O)CCCC(C)C2)C1

nearest known ligand 0.46

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.46
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17892811 0.88 CYP1A2 (0.45) CYP1A2KDM4EALDH1A1TDP1
SCHEMBL15859172 0.87 CYP1A2 (0.53) CYP1A2TDP1
Hydrochloric Acid SCHEMBL27282843 0.82 CYP1A2 (0.44) CYP1A2KDM4EALDH1A1TDP1
SCHEMBL28983033 0.78 CYP1A2 (0.44) CYP1A2KDM4EALDH1A1TDP1
SCHEMBL633175 0.77 CYP2C9 (0.33) CYP1A2
SCHEMBL17892423 0.76 CYP1A2 (0.36) CYP1A2ALDH1A1
SCHEMBL27851170 0.76 CYP1A2 (0.35) CYP1A2KDM4EALDH1A1
SCHEMBL5476177 0.74 CYP1A2 (0.42) CYP1A2TDP1
SCHEMBL6377357 0.74 CYP2C19 (0.34)
SCHEMBL6376842 0.74 FFAR3 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090163652-A1 THERMOSETTING RESIN COMPOSITION AND USE THEREOF CHISSO CORPORATION (JP) 2009-06-25 US claimed
US-10954340-B2 Polyimide precursor composition TOKYO OHKA KOGYO CO., LTD. (JP) 2021-03-23 US disclosed
US-20190185711-A1 EPOXY RESIN COMPOSITION AND CURED RESIN FILM WITH LOW CURING SHRINKAGE AND EXCELLENT ADHESION JNC CORPORATION (JP) 2019-06-20 US disclosed
EP-3330320-B1 POLYIMIDE PRECURSOR COMPOSITION TOKYO OHKA KOGYO CO LTD (JP) 2019-04-24 EP disclosed
US-20180223045-A1 POLYIMIDE PRECURSOR COMPOSITION TOKYO OHKA KOGYO CO., LTD. (JP) 2018-08-09 US disclosed
EP-3330320-A1 POLYIMIDE PRECURSOR COMPOSITION Tokyo Ohka Kogyo Co., Ltd. (JP) 2018-06-06 EP disclosed
US-9753186-B2 Glass fiber-silsesquioxane composite molded article and method for producing same JNC CORPORATION (JP) 2017-09-05 US disclosed
EP-2420529-B1 GLASS FIBER-SILSESQUIOXANE COMPOSITE MOLDED ARTICLE AND METHOD FOR PRODUCING SAME JNC CORP (JP) 2016-10-26 EP disclosed
CN-102395622-B Glass fiber composite semi-siloxane molded body and method for producing same JNC CORP 2015-02-04 CN disclosed
US-8273843-B2 Organosilicon compound and thermosetting resin composition containing the same JNC CORPORATION (JP) 2012-09-25 US disclosed
CN-102395622-A Glass fiber composite semi-siloxane molded body and method for producing same CHISSO CORP 2012-03-28 CN disclosed
US-20120052296-A1 GLASS FIBER-SILSESQUIOXANE COMPOSITE MOLDED ARTICLE AND METHOD FOR PRODUCING SAME JNC CORPORATION (JP) 2012-03-01 US disclosed
EP-2420529-A1 GLASS FIBER-SILSESQUIOXANE COMPOSITE MOLDED ARTICLE AND METHOD FOR PRODUCING SAME JNC Corporation (JP) 2012-02-22 EP disclosed
US-20100273937-A1 ORGANOSILICON COMPOUND AND THERMOSETTING RESIN COMPOSITION CONTAINING THE SAME CHISSO CORPORATION (JP) 2010-10-28 US disclosed
US-20090163652-A1 THERMOSETTING RESIN COMPOSITION AND USE THEREOF CHISSO CORPORATION (JP) 2009-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100273937-A1 ORGANOSILICON COMPOUND AND THERMOSETTING RESIN COMPOSITION CONTAINING THE SAME OR51E2, STS, OXER1 CYP1A2 1174/4885KDM4E 510/4885ALDH1A1 2420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.